Weight Loss Medications What Is New
US$ 22.52
25 semaglutide Kyn-25-Semaglutide | CS-O-48509 TrimRX | How to Inject
Description
Learn about GLP-1s, the type 2 diabetes drugs being used for weight loss
It has not yet been approved or made available, but is currently undergoing extensive research
Mounjaro is a newer option that targets two hormones and can be discussed with healthcare providers for suitable treatment plans
Optimal nutrient absorption
The observations that GLP-1 receptor agonists exert anti-inflammatory actions in preclinical studies, taken together with case reports linking improvements in psoriasis with GLP-1 receptor agonist therapy, illustrates the emerging clinical implications of non-classical anti-inflammatory actions of incretin-based therapeutics.
Meet the winners and read about their accomplishments.
